Zheng-Yi Zhou

6PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyCross-sectional analysisGene and molecular therapyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 20, 2026
Comparative economic analysis of B-cell maturation antigen-targeted bispecific antibodies in triple-class exposed relapsed/refractory multiple myeloma: linvoseltamab versus teclistamab and elranatamab.

|Apr 27, 2026
Berotralstat and Health-Related Quality of Life in Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J Trials.

|Sep 21, 2024
Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis.

Zheng-Yi Zhou, Mark E Bensink, Nisha C Hazra

|Aug 13, 2024
First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data.

Georgina V Long, Evan J Lipson, F Stephen Hodi

|Jan 05, 2021
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States.

Beilei Cai, Zheng-Yi Zhou, Weiguang Xue

|Apr 17, 2016
Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis.

Zheng-Yi Zhou, Jenny Griffith, Ella Xiaoyan Du

Pageof 1

Frequent Collaborators

3 joint publications

Nisha C Hazra

1 joint publications

Beilei Cai

1 joint publications

Weiguang Xue

1 joint publications

Diana Brixner